How did alcohol consumption change during the COVID-19 pandemic in the state of Wisconsin? medrxivpreprint UWMadison UofIllinois alcohol pandemic COVID19 coronavirus covid
By Pooja Toshniwal PahariaNov 10 2022Reviewed by Danielle Ellis, B.Sc. In a recent study posted to the medRxiv* preprint server, researchers evaluated the patterns of alcohol use at three different time points during the coronavirus disease 2019 pandemic in Wisconsin.
A web-based survey was emailed to 5,502 SHOW study participants to obtain data on several COVID-19-associated topics during three waves of the pandemic between 2020 and 2021. In addition, individuals were telephonically contacted, but telephone respondents were excluded from the analysis. The study included more than 25 professors and investigators from the state’s University in Madison.
Results and discussion The surveys were completed by 1,403, 1,889, and 1,615 individuals during the first, second, and third pandemic waves, respectively. During the COVID-19 waves, anxious and younger individuals who had attained a baccalaureate degree and individuals having children at home reported a significantly greater likelihood of consuming more alcohol.
During all waves, the odds of increased drinking during the pandemic were 2.0-fold higher among younger individuals in comparison to 60- to 74-year-old individuals and ≥3.0-fold higher in comparison to individuals aged ≥75 years. During the first, second, and third COVID-19 waves, 35%, 26%, and 21% of individuals having children at home showed a greater likelihood of reporting higher alcohol intake, respectively, compared to 18%, 16%, and 13% of individuals).
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19: The Global COVID-19 Stroke RegistryBackground and objectives: COVID-19 related inflammation, endothelial dysfunction and coagulopathy may increase the bleeding risk and lower efficacy of revascularization treatments in patients with acute ischemic stroke. We aimed to evaluate the safety and outcomes of revascularization treatments in patients with acute ischemic stroke and COVID-19. Methods: Retrospective multicenter cohort study of consecutive patients with acute ischemic stroke receiving intravenous thrombolysis (IVT) and/or endovascular treatment (EVT) between March 2020 and June 2021, tested for SARS-CoV-2 infection. With a doubly-robust model combining propensity score weighting and multivariate regression, we studied the association of COVID-19 with intracranial bleeding complications and clinical outcomes. Subgroup analyses were performed according to treatment groups (IVT-only and EVT). Results: Of a total of 15128 included patients from 105 centers, 853 (5.6%) were diagnosed with COVID-19. 5848 (38.7%) patients received IVT-only, and 9280 (61.3%) EVT (with or without IVT). Patients with COVID-19 had a higher rate of symptomatic intracerebral hemorrhage (SICH) (adjusted odds ratio [OR] 1.53; 95% CI 1.16–2.01), symptomatic subarachnoid hemorrhage (SSAH) (OR 1.80; 95% CI 1.20–2.69), SICH and/or SSAH combined (OR 1.56; 95% CI 1.23–1.99), 24-hour (OR 2.47; 95% CI 1.58–3.86) and 3-month mortality (OR 1.88; 95% CI 1.52–2.33). COVID-19 patients also had an unfavorable shift in the distribution of the modified Rankin score at 3 months (OR 1.42; 95% CI 1.26–1.60). Discussion: Patients with acute ischemic stroke and COVID-19 showed higher rates of intracranial bleeding complications and worse clinical outcomes after revascularization treatments than contemporaneous non-COVID-19 treated patients. Current available data does not allow direct conclusions to be drawn on the effectiveness of revascularization treatments in COVID-19 patients, or to establish different treatment recommendations in this subgro
Weiterlesen »
Does fenofibrate improve clinical outcomes in patients with COVID-19?Does fenofibrate improve clinical outcomes in patients with COVID-19? NatMetabolism Penn udes_oficial COVID19 coronavirus covid metabolism
Weiterlesen »
The comparative risk of myocarditis, pericarditis, and myopericarditis between BNT162b2 and mRNA-1273 second dosesThe comparative risk of myocarditis, pericarditis, and myopericarditis between BNT162b2 and mRNA-1273 second doses UBC UofT vaccine vaccination myocarditis mRNA mRNAvaccine
Weiterlesen »
Financial markets bet on an end to China’s “zero-covid” policyThere are some signs change may be on the way
Weiterlesen »
Does vitamin D reduce COVID-19 severity?A new study examined published studies for a consistent association between vitamin D levels and coronavirus disease 2019 (COVID-19) severity.
Weiterlesen »
Frequent mandatory COVID-19 testing may increase risky behaviorAbstract. Mandatory surveillance testing programs are popular policies aimed to control SARS-Cov-2 and may be considered for future epidemics. However, if peopl
Weiterlesen »